NasdaqGS:TECHLife Sciences
Assessing Bio-Techne (TECH) Valuation After Mixed Long Term Shareholder Returns
Bio-Techne stock: recent performance snapshot
Bio-Techne (TECH) has drawn investor attention after a mixed stretch, with a small gain over the past month alongside a decline over the past 3 months and weaker multi year total returns.
Against that backdrop, the stock last closed at US$54.74, with annual revenue of US$1.22b and net income of US$81.06m. This positions the company as a mid cap player in life science tools and diagnostics.
See our latest analysis for Bio-Techne.
Short term...